Thrivent Financial for Lutherans reduced its stake in shares of IMAX Co. (NYSE:IMAX - Free Report) by 22.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 637,779 shares of the company's stock after selling 181,546 shares during the period. Thrivent Financial for Lutherans owned 1.21% of IMAX worth $13,081,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Huntington National Bank bought a new position in shares of IMAX in the third quarter worth about $34,000. Headlands Technologies LLC purchased a new stake in IMAX in the 2nd quarter worth $35,000. nVerses Capital LLC purchased a new stake in shares of IMAX in the third quarter worth about $70,000. Summit Securities Group LLC bought a new position in shares of IMAX during the 2nd quarter valued at approximately $80,000. Finally, Laurus Investment Counsel Inc. purchased a new position in shares of IMAX in the second quarter valued at $150,000. 93.51% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on IMAX shares. Macquarie lifted their price objective on shares of IMAX from $24.00 to $26.00 and gave the stock an "outperform" rating in a research note on Friday, July 26th. StockNews.com cut IMAX from a "buy" rating to a "hold" rating in a research note on Thursday. Roth Mkm raised their price objective on IMAX from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Thursday, October 31st. Rosenblatt Securities reissued a "buy" rating and set a $28.00 target price on shares of IMAX in a research report on Thursday, October 31st. Finally, Wedbush raised their price target on IMAX from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $24.22.
Read Our Latest Stock Analysis on IMAX
IMAX Stock Up 1.9 %
NYSE:IMAX traded up $0.48 during mid-day trading on Friday, reaching $25.19. The company's stock had a trading volume of 621,620 shares, compared to its average volume of 760,870. The firm has a market capitalization of $1.33 billion, a PE ratio of 57.25, a price-to-earnings-growth ratio of 1.63 and a beta of 1.22. The stock has a fifty day moving average of $21.68 and a 200-day moving average of $19.43. IMAX Co. has a 1 year low of $13.20 and a 1 year high of $25.51.
IMAX (NYSE:IMAX - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.12. The firm had revenue of $91.50 million for the quarter, compared to the consensus estimate of $93.71 million. IMAX had a net margin of 6.74% and a return on equity of 7.53%. The company's quarterly revenue was down 11.9% on a year-over-year basis. During the same period last year, the firm earned $0.27 earnings per share. On average, analysts expect that IMAX Co. will post 0.76 earnings per share for the current year.
IMAX Profile
(
Free Report)
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
See Also
Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.